Can you predict TherapeuticsMD stock price?
Get the latest TherapeuticsMD Inc (TXMD) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
What is TherapeuticsMD's price targets for the next year?
Apr 17, 2022 · TherapeuticsMD's stock was trading at $1.52 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, TXMD shares have decreased by 85.3% and is now trading at $0.2230. View which stocks have been most impacted by COVID-19.
What is TherapeuticsMD's stock symbol?
Current Price: $0.22: Day's Range: $0.22 - $0.24: 52wk Range: $0.18 - $1.39: Volume: 6,514,396: Avg Vol: 8,208,380
What's the price of txmd stock?
Get the latest TherapeuticsMD, Inc. (TXMD) stock news and headlines to help you in your trading and investing decisions.
Is TherapeuticsMD a buy right now?
2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for TherapeuticsMD in the last year. There are currently 2 buy ratings for the...
How has TherapeuticsMD's stock price been impacted by Coronavirus (COVID-19)?
TherapeuticsMD's stock was trading at $1.52 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health O...
When is TherapeuticsMD's next earnings date?
TherapeuticsMD is scheduled to release its next quarterly earnings announcement on Thursday, May 5th 2022. View our earnings forecast for Therapeu...
How were TherapeuticsMD's earnings last quarter?
TherapeuticsMD, Inc. (NASDAQ:TXMD) released its earnings results on Thursday, March, 10th. The company reported ($0.10) EPS for the quarter, missin...
What price target have analysts set for TXMD?
2 equities research analysts have issued 1 year price targets for TherapeuticsMD's shares. Their forecasts range from $2.50 to $5.00. On average, t...
Who are TherapeuticsMD's key executives?
TherapeuticsMD's management team includes the following people: Hugh O'Dowd , President, Chief Executive Officer & Director James C. Darecca , C...
Who are some of TherapeuticsMD's key competitors?
Some companies that are related to TherapeuticsMD include Cara Therapeutics (CARA) , Collegium Pharmaceutical (COLL) , Eagle Pharmaceuticals (EG...
What other stocks do shareholders of TherapeuticsMD own?
Based on aggregate information from My MarketBeat watchlists, some companies that other TherapeuticsMD investors own include OPKO Health (OPK) ,...
What is TherapeuticsMD's stock symbol?
TherapeuticsMD trades on the NASDAQ under the ticker symbol "TXMD."
Is TherapeuticsMD a buy right now?
3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for TherapeuticsMD in the last year. There are currently 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" TherapeuticsMD stock.#N#View analyst ratings for TherapeuticsMD or view top-rated stocks.
What stocks does MarketBeat like better than TherapeuticsMD?
Wall Street analysts have given TherapeuticsMD a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but TherapeuticsMD wasn't one of them.
Are investors shorting TherapeuticsMD?
TherapeuticsMD saw a drop in short interest in the month of August. As of August 13th, there was short interest totaling 22,580,000 shares, a drop of 30.2% from the July 29th total of 32,340,000 shares. Based on an average daily volume of 5,620,000 shares, the days-to-cover ratio is currently 4.0 days.#N#View TherapeuticsMD's Short Interest.
When is TherapeuticsMD's next earnings date?
TherapeuticsMD is scheduled to release its next quarterly earnings announcement on Monday, November 8th 2021.#N#View our earnings forecast for TherapeuticsMD.
How were TherapeuticsMD's earnings last quarter?
TherapeuticsMD, Inc. (NASDAQ:TXMD) posted its quarterly earnings results on Wednesday, August, 4th. The company reported ($0.11) earnings per share for the quarter, hitting the Zacks' consensus estimate of ($0.11).
How has TherapeuticsMD's stock been impacted by Coronavirus (COVID-19)?
TherapeuticsMD's stock was trading at $1.52 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, TXMD stock has decreased by 49.3% and is now trading at $0.77.#N#View which stocks have been most impacted by COVID-19.
What price target have analysts set for TXMD?
3 brokers have issued twelve-month target prices for TherapeuticsMD's shares. Their forecasts range from $4.00 to $5.00. On average, they expect TherapeuticsMD's stock price to reach $4.50 in the next year.
5 Penny Stocks Insiders Are Buying
When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision. Below is a look at a few recent notable insider transactions for penny stocks.
TherapeuticsMD (TXMD) Reports Q2 Loss, Tops Revenue Estimates
TherapeuticsMD (TXMD) delivered earnings and revenue surprises of 0.00% and 1.64%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Will TherapeuticsMD (TXMD) Report Negative Earnings Next Week? What You Should Know
TherapeuticsMD (TXMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
10 Best Pharmaceutical Stocks to Buy According to Billionaire Joseph Edelman
In this article, we will discuss the 10 best pharmaceutical stocks to buy according to billionaire Joseph Edelman. If you want to skip our detailed analysis of Edelman’s history, investment philosophy, and hedge fund performance, go directly to the 5 Best Pharmaceutical Stocks to Buy According to Billionaire Joseph Edelman.
Breakeven On The Horizon For TherapeuticsMD, Inc. (NASDAQ:TXMD)
TherapeuticsMD, Inc. ( NASDAQ:TXMD ) is possibly approaching a major achievement in its business, so we would like to...
TherapeuticsMD, Inc. (TXMD) Q1 2021 Earnings Call Transcript
Thank you for joining us for TherapeuticsMD first-quarter 2020 financial results conference call. This morning, TherapeuticsMD issued a press release announcing our first-quarter financial results.
TherapeuticsMD Shares Plunge On Declining Gross Margin, Total Prescription Volume
View more earnings on TXMDSee more from BenzingaClick here for options trades from BenzingaFusion Pharma Shares Move Higher After Trial Collab With Merck For IGF-1R-Expressing Cancer StudyCardinal Health Stock Tumbles After Q3 Earnings Fall Short Of Expectations; Narrowed FY21 Adjusted EPS Guidance© 2021 Benzinga.com.
TXMD earnings per share forecast
What is TXMD 's earnings per share in the next 3 years based on estimates from 4 analysts?
TXMD revenue forecast
What is TXMD 's revenue in the next 3 years based on estimates from 2 analysts?
TXMD revenue growth forecast
How is TXMD forecast to perform vs Drug Manufacturers - Specialty & Generic companies and vs the US market?
Therapeuticsmd After-Hype Price Prediction Density Analysis
As far as predicting the price of Therapeuticsmd at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range.
Therapeuticsmd Estimiated After-Hype Price Volatility
In the context of predicting Therapeuticsmd's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Therapeuticsmd's historical news coverage. Therapeuticsmd's after-hype downside and upside margins for the prediction period are 0.04 and 4.49, respectively.
Therapeuticsmd Stock Price Prediction Analysis
Have you ever been surprised when a price of a company such as Therapeuticsmd is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Therapeuticsmd backward and forwards among themselves.
Therapeuticsmd Hype Timeline
Therapeuticsmd is at this time traded for 0.78. The entity has historical hype elasticity of -0.02 and average elasticity to hype of competition of -0.16. Therapeuticsmd is expected to decline in value after the next headline with price expected to drop to 0.76. The average volatility ofmedia hypeimpact on the company stock price is over 100%.
Therapeuticsmd Related Hype Analysis
Having access to credible news sources related to Therapeuticsmd's direct competition is more important than ever and may enhance your ability to predict Therapeuticsmd's future price movements.
Therapeuticsmd Additional Predictive Modules
Most predictive techniques to examine Therapeuticsmd price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Therapeuticsmd using various technical indicators.
About Therapeuticsmd Predictive Indicators
The successful prediction of Therapeuticsmd stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Therapeuticsmd, already reflect all publicly available information.
What is TherapeuticsMD stock?
TherapeuticsMD ( NASDAQ:TXMD) is a small-cap pharmaceutical stock that focuses on women's health issues. The company is still in its early growth stages, but with three products already in its portfolio, it could be an attractive growth opportunity for investors today.
Who is David Jagielski?
David Jagielski is a designated accountant and has spent 10+ years working in finance for small and large businesses in many different sectors. He has been writing for The Fool since 2017. When he's not out hunting for cheap stocks or writing articles, odds are he's writing macros in Excel or reading history books. Follow @davidjagielski.
